Use of the reductive glycine pathway for generating formatotrophic and autotrophic microorganisms

US10377994B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10377994-B2
Application numberUS-201816162427-A
CountryUS
Kind codeB2
Filing dateOct 17, 2018
Priority dateJul 29, 2012
Publication dateAug 13, 2019
Grant dateAug 13, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An isolated microorganism that expresses enzymes of the reductive glycine pathway is disclosed. The microorganism is capable of converting formate to pyruvate or glycerate via the formation of glycine and serine. Methods of generating same are further described.

First claim

Opening claim text (preview).

What is claimed is: 1. An isolated microoranism that is genetically modified to overexpress at least one enzyme of the glycine cleavage system, said enzyme being selected from the group consisting of EC 2.1.2.10, EC1.8.1.4 and EC 1.4.4.2, wherein the microorganism is able to utilize formate as a carbon source for the generation of pyruvate or glycerate via the formation of glycine and serine. 2. An isolated microorganism that is genetically modified to express enzymes of the reductive glycine pathway, wherein the microorganism is capable of converting formate to a metabolite of central metabolism via the formation of glycine and without the formation of serine, said metabolite being selected from the group consisting of acetyl CoA, oxaloacetate, glycerate 2-phosphate and glycerate 3-phosphate, wherein said microorganism uses formate as its carbon source. 3. The microorganism of claim 2 , not expressing EC 2.1.2.1. 4. The microorganism of claim 1 , further expressing a formate dehydrogenase which is capable of reducing carbon dioxide to formic acid. 5. The microorganism of claim 1 , selected from the group consisting of a fungus and an algae. 6. The microorganism of claim 2 , selected from the group consisting of a bacteria, a fungus and an algae. 7. The microorganism of claim 1 , being genetically modified to express a human polypeptide. 8. The microorganism of claim 1 , capable of producing a biofuel. 9. A method of generating a microorganism comprising overexpressing in the microorganism at least one enzyme of the glycine cleavage system, said enzyme being selected from the group consisting of EC 2.1.2.10, EC1.8.1.4 and EC 1.4.4.2, wherein the microorganism is capable of utilizing formate as a carbon source for the generation of pyruvate or glycerate via the formation of glycine and serine. 10. The method of claim 9 , wherein said microorganism is formatotrophic. 11. The method of claim 9 , wherein said microorganism is autotrophic. 12. The method of claim 10 , further comprising selecting the microorganism that is formatotrophic by growing the microorganism on formate following said expressing. 13. The method of claim 11 , further comprising selecting the microorganism that is autotrophic by growing the microorganism on carbon dioxide in the presence of an external electron source following said expressing. 14. The method of claim 9 , further comprising culturing said microorganism following said generating. 15. The method of claim 14 , wherein said culturing is effected in a presence of an electrical current so as to generate said formate. 16. The microorganism of claim 1 , further expressing a NAD-dependent formate dehydrogenase which is capable of oxidizing formate to carbon dioxide. 17. The microorganism of claim 2 , further expressing a NAD-dependent formate dehydrogenase which is capable of oxidizing formate to carbon dioxide. 18. The microorganism of claim 5 , wherein the fungus is a yeast. 19. The microorganism of claim 6 , wherein the fungus is a yeast.

Assignees

Inventors

Classifications

  • Ligases (6) · CPC title

  • containing a carboxyl group {including Peroxycarboxylic acids} · CPC title

  • Formate--tetrahydrofolate ligase (6.3.4.3) · CPC title

  • Genes encoding for enzymes or proenzymes · CPC title

  • Formate dehydrogenase (1.2.1.2) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10377994B2 cover?
An isolated microorganism that expresses enzymes of the reductive glycine pathway is disclosed. The microorganism is capable of converting formate to pyruvate or glycerate via the formation of glycine and serine. Methods of generating same are further described.
Who is the assignee on this patent?
Yeda Res & Dev, Yeda Res And Developmetn Co Ltd
What technology area does this patent fall under?
Primary CPC classification C12N9/0008. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 13 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).